1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Summary: The fiscal year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors and interventions. The ORP intends for research supported by this mechanism to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Applications must address how the proposed research will impact patient care and reduce the burden of orthopaedic injury and sequela. The ORP expects that research findings benefit Service Members, their families, Veterans and the general public. To meet the intent of the award mechanism, applications must specifically address at least one of the FY26 ORP CRA Focus Areas.Distinctive Features: · The CRA offers two research levels.Research Level 1 (RL1) supports clinical research in the following FY26 ORP focus areas:· Ligamentous Trauma· Osseointegration Outcomes· Return-to-Duty Strategies· Military Women’s HealthResearch Level 2 (RL2) supports clinical trials in the following FY26 ORP focus areas:· Ligamentous Trauma· Limb Stabilization and Protection· Return-to-Duty Strategies
Funding Opportunity Number: HT942526ORPCRA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $13.6M total program funding.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility. Confirm the full requirements in the official notice before applying.
The current listing shows $13.6M total program funding. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for DoW Orthopaedic, Clinical Research Award are due November 18, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Yes — DoW Orthopaedic, Clinical Research Award is offered by Dept. of the Army -- USAMRAA and this listing comes from Grants.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial, but not a full-scale clinical trial. Research must align with at least one of the FY26 VRP Focus Areas. Distinctive Features: · If developing new drugs or device(s), the research team must include expertise in the regulatory approval process. · The TRA includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI. · Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, Personnel and Post-Award Transition Plan. · Programmatic review criteria include adherence to the intent of the TRA, contribution to the VRP portfolio, relative impact and relevance to military health. · The VRP may share FY26 TRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration. https://cdmrp.health.mil/pubs/press/2026/vrppreann Funding Opportunity Number: HT942526VRPTRA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $1.6M total program funding.
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas. Distinctive Features: · For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, in order for the CTA application to be considered for funding. Refer to Attachment 7: Regulatory Strategy for further details. · Scored peer review criteria include Clinical Impact; Research Strategy and Feasibility; Recruitment, Accrual, Retention; Regulatory Strategy and Transition Plan; Statistical Plan and Data Analysis; Ethical Considerations; Personnel and Communication. · Programmatic review criteria include adherence to the intent of the CTA, contribution to program portfolio, relative impact and relevance to military health. https://cdmrp.health.mil/pubs/press/2026/vrppreann Funding Opportunity Number: HT942526VRPCTA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $2.6M total program funding.
Orthopaedic Research Program (ORP) Applied Research Award is sponsored by Department of Defense, Defense Health Agency Contracting Activity - DHACA. The Orthopaedic Research Program (ORP) Applied Research Award (ARA) focuses on applied research to advance optimal treatment and restoration of function for individuals with orthopaedic injuries sustained during combat or service-related activities.
Orthopaedic Research Program (ORP) Clinical Research Award is sponsored by Department of Defense, Defense Health Agency Contracting Activity - DHACA. The FY26 Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors and interventions with the potential to optimize patient outcomes and inform clinical care or policy.
After SBIR reauthorization, the U.S. Army released five new small-business topics under Army FUZE — Ka-Band metamaterial radar, a Li-ion 6T battery open topic, in-transit-visibility blockchain, modular UAS payloads, and the xTech|Phantum prize competition. Awards run from $150K to $300K per Phase I. But the bigger story is the Army's shift from funding parts to funding whole systems. Here is what each topic funds and how to compete.
Read articleDARPA transferred its first autonomous-ready H-60Mx Black Hawk to the Army on March 20, capping a decade of ALIAS research. Now the same technology underpins an SBIR XL opportunity for small businesses building wildfire autonomy.
Read articleW912HZ26S0001 is continuously open across seven Army laboratories and more than 100 topic areas. Five pages, a 60-day answer, no per-award cap, and no application window to miss. The aggregator sites listing it with a deadline are reading the wrong field.
Read article